NIH Provides Funds for GSN's Prenatal Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing firm Gene Security Network has received a $2 million grant from the National Institutes of Health to conduct a clinical trial for its non-invasive prenatal diagnosis (NIPD) technology.

GSN will use the funding to conduct a randomized clinical trial for its Parental Support NIPD test. The research phase of the clinical study has already begun, and the prospective trial is scheduled to start later this year, the Redwood, Calif.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.